Skip to main content
Premium Trial:

Request an Annual Quote

FDA to Use Rosetta s Resolver System for Data Submission Analysis

NEW YORK, Aug. 24 (GenomeWeb News) - The US Food and Drug Administration will use Rosetta Biosoftware's Rosetta Resolver system for genomic data management and analysis in order to analyze microarray data from sponsors, Rosetta said today.

According to Rosetta, the Center for Drug Evaluation and Research, an arm of the FDA, will use the system when evaluating genomic data submitted through the voluntary genomic data submissions program the agency initiated this year.

The system will be used to "understand, learn from, and reproduce analyses conducted by pharmaceutical companies who voluntarily submit genomics data," Rosetta said.

Financial details were not discussed.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.